GlassScriptPrepare for your visit
Rahul Dev Polineni
Medical Oncology · Corona, CA · NPI 1235375155
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,069.99
in general payments reported to CMS, 2019-2025 · $139 in 2025
The $139 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Who reported paying
General payments only, top 6 by amount.
- E.R. Squibb & Sons, L.L.C. $1,070.84
- Pfizer INC. $518.49
- Genzyme Corporation $497.83
- Novartis Pharmaceuticals Corporation $426.47
- Merck Sharp & Dohme LLC $426.22
- Genentech USA, INC. $383.73
Drugs and devices associated with these payments
Imbruvica Scemblix Xpovio Keytruda Sarclisa Oxbryta Pluvicto Venclexta Darzalex Tazverik Xtandi Lutathera
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Rahul Dev Polineni listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1295525/rahul-dev-polineni